Copyright Reports & Markets. All rights reserved.

Global Transcutaneous Neurostimulators Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Transcutaneous Neurostimulators Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Transcutaneous Neurostimulators Market Size Growth Rate by Product
      • 1.4.2 Sensory Nerve Stimulation
      • 1.4.3 Vagus Nerve Stimulation
      • 1.4.4 Peripheral Nerve Stimulation
    • 1.5 Market by End User
      • 1.5.1 Global Transcutaneous Neurostimulators Market Size Growth Rate by End User
      • 1.5.2 Hospiatl
      • 1.5.3 Clinic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Transcutaneous Neurostimulators Market Size
      • 2.1.1 Global Transcutaneous Neurostimulators Revenue 2014-2025
      • 2.1.2 Global Transcutaneous Neurostimulators Sales 2014-2025
    • 2.2 Transcutaneous Neurostimulators Growth Rate by Regions
      • 2.2.1 Global Transcutaneous Neurostimulators Sales by Regions
      • 2.2.2 Global Transcutaneous Neurostimulators Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Transcutaneous Neurostimulators Sales by Manufacturers
      • 3.1.1 Transcutaneous Neurostimulators Sales by Manufacturers
      • 3.1.2 Transcutaneous Neurostimulators Sales Market Share by Manufacturers
      • 3.1.3 Global Transcutaneous Neurostimulators Market Concentration Ratio (CR5 and HHI)
    • 3.2 Transcutaneous Neurostimulators Revenue by Manufacturers
      • 3.2.1 Transcutaneous Neurostimulators Revenue by Manufacturers (2014-2019)
      • 3.2.2 Transcutaneous Neurostimulators Revenue Share by Manufacturers (2014-2019)
    • 3.3 Transcutaneous Neurostimulators Price by Manufacturers
    • 3.4 Transcutaneous Neurostimulators Manufacturing Base Distribution, Product Types
      • 3.4.1 Transcutaneous Neurostimulators Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Transcutaneous Neurostimulators Product Type
      • 3.4.3 Date of International Manufacturers Enter into Transcutaneous Neurostimulators Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Transcutaneous Neurostimulators Sales by Product
    • 4.2 Global Transcutaneous Neurostimulators Revenue by Product
    • 4.3 Transcutaneous Neurostimulators Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Transcutaneous Neurostimulators Breakdown Data by End User

    6 North America

    • 6.1 North America Transcutaneous Neurostimulators by Countries
      • 6.1.1 North America Transcutaneous Neurostimulators Sales by Countries
      • 6.1.2 North America Transcutaneous Neurostimulators Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Transcutaneous Neurostimulators by Product
    • 6.3 North America Transcutaneous Neurostimulators by End User

    7 Europe

    • 7.1 Europe Transcutaneous Neurostimulators by Countries
      • 7.1.1 Europe Transcutaneous Neurostimulators Sales by Countries
      • 7.1.2 Europe Transcutaneous Neurostimulators Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Transcutaneous Neurostimulators by Product
    • 7.3 Europe Transcutaneous Neurostimulators by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Transcutaneous Neurostimulators by Countries
      • 8.1.1 Asia Pacific Transcutaneous Neurostimulators Sales by Countries
      • 8.1.2 Asia Pacific Transcutaneous Neurostimulators Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Transcutaneous Neurostimulators by Product
    • 8.3 Asia Pacific Transcutaneous Neurostimulators by End User

    9 Central & South America

    • 9.1 Central & South America Transcutaneous Neurostimulators by Countries
      • 9.1.1 Central & South America Transcutaneous Neurostimulators Sales by Countries
      • 9.1.2 Central & South America Transcutaneous Neurostimulators Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Transcutaneous Neurostimulators by Product
    • 9.3 Central & South America Transcutaneous Neurostimulators by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Transcutaneous Neurostimulators by Countries
      • 10.1.1 Middle East and Africa Transcutaneous Neurostimulators Sales by Countries
      • 10.1.2 Middle East and Africa Transcutaneous Neurostimulators Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Transcutaneous Neurostimulators by Product
    • 10.3 Middle East and Africa Transcutaneous Neurostimulators by End User

    11 Company Profiles

    • 11.1 ElectroCore Medical
      • 11.1.1 ElectroCore Medical Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 ElectroCore Medical Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 ElectroCore Medical Transcutaneous Neurostimulators Products Offered
      • 11.1.5 ElectroCore Medical Recent Development
    • 11.2 NEUROMetrix
      • 11.2.1 NEUROMetrix Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 NEUROMetrix Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 NEUROMetrix Transcutaneous Neurostimulators Products Offered
      • 11.2.5 NEUROMetrix Recent Development
    • 11.3 Neurosigma
      • 11.3.1 Neurosigma Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Neurosigma Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Neurosigma Transcutaneous Neurostimulators Products Offered
      • 11.3.5 Neurosigma Recent Development
    • 11.4 Quell
      • 11.4.1 Quell Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Quell Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Quell Transcutaneous Neurostimulators Products Offered
      • 11.4.5 Quell Recent Development
    • 11.5 Vygon
      • 11.5.1 Vygon Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Vygon Transcutaneous Neurostimulators Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Vygon Transcutaneous Neurostimulators Products Offered
      • 11.5.5 Vygon Recent Development

    12 Future Forecast

    • 12.1 Transcutaneous Neurostimulators Market Forecast by Regions
      • 12.1.1 Global Transcutaneous Neurostimulators Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Transcutaneous Neurostimulators Revenue Forecast by Regions 2019-2025
    • 12.2 Transcutaneous Neurostimulators Market Forecast by Product
      • 12.2.1 Global Transcutaneous Neurostimulators Sales Forecast by Product 2019-2025
      • 12.2.2 Global Transcutaneous Neurostimulators Revenue Forecast by Product 2019-2025
    • 12.3 Transcutaneous Neurostimulators Market Forecast by End User
    • 12.4 North America Transcutaneous Neurostimulators Forecast
    • 12.5 Europe Transcutaneous Neurostimulators Forecast
    • 12.6 Asia Pacific Transcutaneous Neurostimulators Forecast
    • 12.7 Central & South America Transcutaneous Neurostimulators Forecast
    • 12.8 Middle East and Africa Transcutaneous Neurostimulators Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Transcutaneous Neurostimulators Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Transcutaneous Neurostimulators market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transcutaneous Neurostimulators market based on company, product type, end user and key regions.

      This report studies the global market size of Transcutaneous Neurostimulators in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transcutaneous Neurostimulators in these regions.
      This research report categorizes the global Transcutaneous Neurostimulators market by top players/brands, region, type and end user. This report also studies the global Transcutaneous Neurostimulators market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      ElectroCore Medical
      NEUROMetrix
      Neurosigma
      Quell
      Vygon 

      Market size by Product
      Sensory Nerve Stimulation
      Vagus Nerve Stimulation
      Peripheral Nerve Stimulation
      Market size by End User
      Hospiatl
      Clinic

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Transcutaneous Neurostimulators market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Transcutaneous Neurostimulators market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Transcutaneous Neurostimulators companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Transcutaneous Neurostimulators submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Transcutaneous Neurostimulators are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transcutaneous Neurostimulators market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now